The tweet was deleted by the author.
But we saved everything 🙂.
OptimizeRx, a company focused on digital health communications, is set to participate in the upcoming MM+M Transform conference in New York City.
John Schaetzle of OptimizeRx will join industry leaders in a panel session titled Can We Now Truly Be Patient-Centric? The session will examine whether the pharmaceutical industry can finally implement the promise of patient-centric marketing and how artificial intelligence and opt-in technologies could change engagement models for patients.
The conversation at MM+M Transform arrives as the healthcare sector continues to grapple with persistent challenges in patient engagement—an issue highlighted when OptimizeRx warned that up to 30% of DTC audiences are lost during onboarding due to identity fragmentation. Meanwhile, as new strategies for patient-centricity take shape, ongoing debates around the effectiveness of point of care marketing remain salient, building on prior scrutiny as OptimizeRx sought to challenge prevailing myths in point of care marketing at major industry forums.